Verified July 2026 · Cited to primary sources

Best Peptides for Muscle Growth (2026): Ranked by Evidence

The GH-axis peptides marketed for muscle and body recomposition, graded by human evidence and legal status. Most of the hype (CJC-1295/Ipamorelin) rests on a single pharmacokinetic study — not proof of muscle gain.

Strongest human evidence in this category

TesamorelinGrade A

Sermorelin (Grade B) is the best-evidenced option with a legal compounding route. Tesamorelin (Grade A) is proven for visceral fat but approved only for HIV lipodystrophy. CJC-1295/Ipamorelin (Grade C) raises GH/IGF-1 in one study but has no trial showing it builds muscle — and it is not legally compoundable.

How we ranked these

Three criteria, applied the same way to every peptide.

We don't rank by popularity or by what we can sell you. Every peptide below is ordered by the same fixed rubric — affiliate availability never moves a grade.

  1. 1Strength of human evidence — the A–F Evidence Grade. FDA approval and published human RCTs at the top (A); animal-only and failed-in-humans at the bottom (D–F). This is the primary sort key.
  2. 2Legal accessibility — a separate factual badge: FDA-approved, compoundable (503A), under FDA review, research-only, or legal topical cosmetic.
  3. 3Safety profile — a green/amber/red flag for how well-characterized the human safety data is. Documented harms or disproven-but-still-sold earns red.

FDA testing has found roughly 40% of online and compounded peptides carried incorrect dosages or undeclared ingredients — the reason a rubric like this exists. See the full A–F methodology →

The ranking, in order of evidence.

  1. 1. Tesamorelin

    Grade AFDA-approved / proven in humans

    A GHRH analog that stimulates the pituitary to release growth hormone, which reduces visceral (abdominal) fat.

    Tesamorelin is an FDA-approved drug (Egrifta, 2010) — Grade A, the strongest evidence tier here. But it is approved for HIV-associated visceral fat, not general weight loss; for that, approved GLP-1s are the evidence-backed route.

    See the evidence →

  2. 2. Sermorelin

    Grade BReal human trials, limited or historical

    Stimulates natural pituitary growth-hormone release as the shortest active GHRH(1-29) fragment — the "gentler," physiologic GH-axis peptide.

    Sermorelin is legally compoundable (503A) thanks to its prior FDA approval as Geref. Human evidence is Grade B — real historical trial data. It is the best-evidenced GH-axis peptide with a legal supervised route today.

    See the evidence →

  3. 3. CJC-1295 / Ipamorelin

    Grade CEarly / foreign human data only

    CJC-1295 (a GHRH analog) drives sustained pituitary GH/IGF-1 release while Ipamorelin (a selective ghrelin/GHS-R agonist) adds a clean GH pulse — the stack aims to raise GH/IGF-1.

    CJC-1295/Ipamorelin is not FDA-approved and is not legally compoundable (CJC-1295 withdrawn April 2026). Human evidence is Grade C — one PK study proves it raises GH/IGF-1, but no trial shows muscle or fat-loss benefit. Researching CJC-1295 on its own (often "with DAC")? See our standalone CJC-1295 page.

    See the evidence →

  4. 4. CJC-1295

    Grade CEarly / foreign human data only

    A modified GHRH analog that stimulates sustained pituitary GH and IGF-1 release; the "with DAC" (Drug Affinity Complex) version binds albumin to extend its half-life to days, versus the shorter-acting no-DAC form (Mod-GRF 1-29).

    CJC-1295 (mono GHRH analog, usually "with DAC") is not FDA-approved and not legally compoundable — its nomination was withdrawn in April 2026. Human evidence is Grade C: one PK study proves it raises GH/IGF-1, but no trial shows muscle or fat-loss benefit. Most people search for the popular blend — see our CJC-1295 / Ipamorelin page. We don't link gray-market sources.

    See the evidence →

  5. 5. IGF-1 LR3

    Grade DAnimal studies only, unproven in humans

    A modified, long-acting form of IGF-1 that activates the IGF-1 receptor to drive the PI3K/Akt/mTOR protein-synthesis and satellite-cell pathways — the theoretical basis for its muscle-growth marketing.

    IGF-1 LR3 is not FDA-approved and not legally compoundable — research-only. Human evidence is Grade D: there is no published human efficacy trial for the analogue itself, so the muscle-growth claims rest on mechanism, not proof. It is also WADA-prohibited (S2). We don't link gray-market sources.

    See the evidence →

Muscle Growth: 5 peptides, ranked by evidence.

Peptides marketed for muscle growth, ranked by strength of human evidence, with legal status and typical cost.
PeptideEvidence
Tesamorelin

One of only two FDA-approved peptides in this space — proven to cut visceral fat, but approved for a narrow HIV indication.

Grade A

FDA-approved / proven in humans

See the evidence →
Sermorelin

The "gentler," formerly-FDA-approved GH-axis peptide — the best-evidenced option you can still legally get through a compounding pharmacy.

Grade B

Real human trials, limited or historical

See the evidence →
CJC-1295 / Ipamorelin

The classic GH-boosting stack — one human PK study shows it raises GH/IGF-1, but no trial shows it builds muscle or burns fat.

Grade C

Early / foreign human data only

See the evidence →
CJC-1295

A GHRH analog — usually the long-acting "with DAC" version — that one human study shows raises GH/IGF-1, but no trial shows it builds muscle or burns fat.

Grade C

Early / foreign human data only

See the evidence →
IGF-1 LR3

A long-acting IGF-1 analogue marketed for muscle growth on the strength of its mechanism alone — there is no published human efficacy trial for it, and it's banned in sport.

Grade D

Animal studies only, unproven in humans

See the evidence →

Reading this table: Evidence is the A–F human-proof grade; Legal status and Safety are separate factual badges; Verdict is our honest one-line take. Affiliate availability never changes a grade. Full methodology.

FAQ

Best peptides for Muscle Growth: FAQ

What is the best peptide for muscle growth?

The best-evidenced option with a legal route is sermorelin (Grade B), a formerly FDA-approved GHRH analog that is still legally compoundable. Tesamorelin (Grade A) is proven to cut visceral fat but is approved only for HIV lipodystrophy. CJC-1295/Ipamorelin (Grade C) raises GH and IGF-1 in one study, but no trial shows it builds muscle.

Does CJC-1295/Ipamorelin build muscle?

There is no human trial showing CJC-1295/Ipamorelin builds muscle or burns fat. The only human data is a pharmacokinetic study confirming it raises GH and IGF-1 — which is why we grade it C. It is also not legally compoundable.

Are muscle-building peptides legal?

Sermorelin is legally compoundable through a 503A pharmacy because of its prior FDA approval. CJC-1295/Ipamorelin is effectively research-only after CJC-1295's compounding nomination was withdrawn in April 2026. All of these are on the WADA Prohibited List for tested athletes.

Read the evidence

Before you buy anything

Other goals

The monthly peptide evidence brief.

What the research and the FDA actually say — one short email a month. Unsubscribe anytime.

No spam. We never sell your email. Editorial policy.